8-K: Therapeutic Solutions International Announces Loyalty Dividend in Breathe Biologics Shares

Therapeutic Solutions International (TSOI) will issue a one-time loyalty dividend of Breathe Biologics (BRTH) shares to TSOI shareholders.

Summary

• Therapeutic Solutions International, Inc. (TSOI) has announced a one-time loyalty dividend to be awarded to TSOI stockholders in subsidiary Breathe Biologics, Inc. (BRTH).
• The dividend was approved by the Board of Directors of TSOI and the Preferred A Stock holders on or about February 15, 2025.
• To be eligible for the dividend, shareholders must hold TSOI common stock at the market close on March 03, 2025.
• The dividend rate is 0.001293129082553 shares of BRTH for every share of TSOI held.
• TSOI owns 22,500,000 shares (86.53%) of BRTH common stock and will issue 7,500,000 shares of its BRTH holdings as the loyalty dividend.
• The Dividend Offer will remain open for Sixty (60) days from the Dividend Offer Date to May 3, 2025.
• A second 8-K will be published on or about May 03, 2025, containing the forms required to elect to receive the dividend.
• Shareholders will need to provide a statement from their brokerage account showing TSOI shares held on March 3, 2025, along with the completed form.
• TSOI will return a Book Entry Statement in the name used in the forms.

Sentiment

Score: 7

Explanation: The announcement of a loyalty dividend is generally positive for shareholders, indicating the company's confidence in its subsidiary.

Positives

• Shareholders receive a dividend in the form of shares in a subsidiary company, BRTH.
• The dividend is a one-time loyalty reward for holding TSOI stock.

Risks

• The value of the BRTH shares received as a dividend may fluctuate.
• Shareholders must actively elect to receive the dividend by completing and submitting the required forms.

Future Outlook

The company will publish a second 8-K on or about May 3, 2025, with instructions for shareholders to claim their dividend.

Industry Context

Companies sometimes issue dividends in the form of shares in subsidiaries to reward shareholders and potentially unlock value.

Stakeholder Impact

• Shareholders will receive a dividend in the form of BRTH shares.
• The dividend may increase shareholder value if BRTH performs well.

Next Steps

• TSOI will publish a second 8-K on or about May 3, 2025, with instructions for shareholders to claim their dividend.
• Shareholders must hold TSOI stock on March 3, 2025, to be eligible for the dividend.
• Shareholders must complete and submit the required forms to elect to receive the dividend.

Key Dates

Keywords

loyalty dividend, Breathe Biologics, Therapeutic Solutions International, TSOI, BRTH, dividend, shareholders